Phosphoramidite Market, By type (DNA-RNA phosphoramidite, speciality phosphoramidite, dye-labeled phosphoramidite and Others), By Modification methods (Base modification, sugar modification and others), By End-user (Molecular Diagnostics, Pharmaceuticals, and life science Research company), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

A phosphoramidite (RO)2PNR2 is a phosphite diester monoamide. Phosphoramidite chemistry is the industry's gold standard process for DNA synthesis, having been used for nearly 35 years. It is currently the only commercially viable chemistry capable of producing the amount of DNA needed by the synthetic biology industry. Nucleoside phosphoramidites are phosphoramidites derived from secured nucleosides that are commonly used in the chemical synthesis of DNA, RNA, and other nucleic acids and their analogues. In asymmetric synthesis, some phosphoramidites are often used as monodentate chiral ligands. TheraPure RNA phosphoramidites have emerged as the gold standard for developing and producing RNA-based therapeutic oligonucleotides as RNA becomes a key driver of therapeutic technologies.Phosphoramidite market accounted for US$ 1.26 billion in 2020 and is estimated to be US$ 2.59 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Impact of Covid-19 pandemic on market

The pandemic of COVID-19 has created a difficult situation for players in the phosphoramidite market. Because of the pandemic's widespread nature and the human toll it has taken, market players are finding it difficult to react. This has resulted in a number of shifts in economic conditions.

Growth in business operations by emerging and small sized players

Because of their high performance, research institutes and diagnostic centres have shifted their attention to genomics and genetics, which has boosted demand for high-quality synthesised oligonucleotides in the phosphoramidites market in recent years. Phosphoramidites are modified nucleosides that are commonly used in DNA synthesis today. Today, phosphoramidites come in a variety of modified forms, each with properties tailored to particular DNA synthesis processes. Today, phosphoramidites and their modified forms are the gold standard in DNA synthesis.

Phosphoramidite market is segmented based on type, modification method, end-user, and region.

On the basis of type, the phosphoramidite market is segmented into DNA-RNA Phosphoramidite, speciality phosphoramidite, dye-labeled phosphoramidite and others. Based on modification method, the target market is segmented into base modification, sugar modification and others. On the basis of End-user, the target market is segmented into molecular diagnostic, Pharmaceuticals, and Life Science Research Company

Regional Insights:

On region the phosphoramidite market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of rising awareness about the rising prevalence of gene-related diseases, rising research on the treatment and diagnosis of these diseases, and the presence of highly developed research infrastructure, North America is expected to dominate the global phosphoramidites market in the future.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the phosphoramidite market report based on type, modification, end-user and region.

Phosphoramidite Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the phosphoramidite market includes Thermo Fisher Scientific, Integrated DNA Technologies, Inc, Sigma-Aldrich Corporation, GE Healthcare, TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, and Shanghai SynTheAll Pharmaceutical Co., Ltd.

• Thermo Fisher Scientific, Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Integrated DNA Technologies, Inc.
• Sigma-Aldrich Corporation
• GE Healthcare
• TriLink BioTechnologies, Inc.
• BioAutomation Corporation
• Twist Bioscience
• Shanghai SynTheAll Pharmaceutical Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section